ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014

Obituary: Daniel Nathans, 71, Won Nobel For Use of Restriction Enzyme

November 19, 1999

UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs

June 28, 1996

Gigliotti Appointed Chief of Education Branch In DRCCA

January 21, 1983

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983

On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials

September 17, 1999